SLDB - Solid Biosciences Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents86,36652,0807,67828,595
Short Term Investments36,09817,01429,98026,792
Net Receivables----
Inventory----
Other Current Assets4,3651,0162,079221
Total Current Assets128,63970,65839,97255,696
Long Term Investments----
Property, plant and equipment10,4222,429452-
Goodwill----
Intangible Assets----
Accumulated Amortization----
Other Assets5363,106212-
Deferred Long Term Asset Charges----
Total Assets139,59776,19340,63655,696
Current Liabilities
Accounts Payable3,6915,0662,984608
Short/Current Long Term Debt----
Other Current Liabilities38223334512,004
Total Current Liabilities12,48111,2716,87313,924
Long Term Debt----
Other Liabilities1,074---
Deferred Long Term Liability Charges-3,10647-
Minority Interest--46,47447,588
Negative Goodwill----
Total Liabilities14,41411,2716,87313,924
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock3565,014558208
Retained Earnings-199,056-124,258-84,941-67,711
Treasury Stock-5-1323-10
Capital Surplus324,209---
Other Stockholder Equity-5-1323-10
Total stockholders' equity125,183-59,257-84,360-67,513
Net Tangible Assets125,183-59,257-84,360-67,513